Skip to content

DL PHARMACARE

Active
Private limited companyfounded 2025active for 1 yearLoofstraat 2, 3670 Oudsbergen, BelgiumKBO/BCE: BE 1026.944.839
Summary

DL PHARMACARE has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €56,107 and a net result of €51,107. Its solvency ranks better than 10% of 10,818 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 28-08-2025 Normal situation
Activity
Business and other management consultancy NACE 70200and 3 others
Establishment unit
2.377.545.422 3670 Oudsbergen, since 28-08-2025
Financial year end
31 December
Peppol
Reachable since 09-09-2025

Board and ownership

Board

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€86,376
Turnover
≈ €170,000
estimated
Profit
€51,107
Equity
€56,107
Total assets
€2.5m
  • 2025 accounts filed 14 days after the deadline
Score breakdownraises riskEquity €56,107 (2.3% of total assets)lowers riskSize: total assets €2.5mSector: Activities of head offices; management consultancy activities (NACE 70)Figures for financial year 2025 (filed on 15-08-2026)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 34% of small companies in head offices and management consultancy (NACE 70)
Financial strength
Weak
Solvency 27
equity 2.3% of total assets
Liquidity 51
short-term debt 13.0% · cash 2.2%
Profitability 54
return on assets 2.1%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (4,516 companies, NACE 70, small)
Last 24 months 09-2026: 0.1%highest value 10-2026: 0.1%● unchanged vs 09-2026highest value 11-2026: 0.1%● unchanged vs 10-2026highest value
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.17, below 1. Short-term debt is 13% and cash 2.2% of total assets. 97.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, small). It does better than 6% of them on solvency, 53% on liquidity and 42% on profitability.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Seven signals.
lowers riskraises risk
lowers risk · Size: total assets €2.5m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Sector: Activities of head offices; management consultancy activities (NACE 70)
KBO
lowers risk · Figures for financial year 2025 (filed on 15-08-2026)
NBB · annual accounts
raises risk · Equity €56,107 (2.3% of total assets)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 10% of 10818 sector peers (2025).
NBB · sector comparison
Position among 10818 sector peers
Solvency
better than 10%
← weakest strongest →
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
raises risk · 2025 accounts filed 14 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-08-2026, 14 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filing
Deviation from the deadline
2025
14 days late
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Key points

  • Caution: Lower solvency than 90% of companies in head offices and management consultancysector median 52.4% · 10,818 companies 2.3% View

Recent changes

  1. · Gazette deed IncorporationAppointment: LEENDERS Nikki (director)
All 2 events

Comparable companies

These companies have the same main activity as DL PHARMACARE: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €1.5m and €3.3m, founded between 2024 and 2025.

CompanyTotal assetsGross margin
DL PHARMACARE Oudsbergen€2.5m€0.09m
District3 Hasselt€2.2m€0.1m
TUBUS Wevelgem€3.3m€0.06m
LRD Invest Ciney€2.2m€0.1m
F.G.F. Holding Herstal€1.9m€0.1m
HOLDING PROFILE Chaudfontaine€1.6m€0.1m
M-CABS Oupeye€1.5m€0.08m
Full comparison

Key facts about DL PHARMACARE

What is the company number of DL PHARMACARE?
The company number of DL PHARMACARE is 1026.944.839. The VAT number is the same number with BE in front: BE 1026.944.839.
Where is DL PHARMACARE based?
The registered office is at Loofstraat 2, 3670 Oudsbergen.Company details
What does DL PHARMACARE do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of DL PHARMACARE?
The legal form of DL PHARMACARE is Private limited company (BV).
When was DL PHARMACARE founded?
DL PHARMACARE was founded on 28-08-2025.
Is DL PHARMACARE still active?
Yes, DL PHARMACARE is an active enterprise in the KBO register.
What is the turnover of DL PHARMACARE?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €86,376 and 64 comparable companies (NACE 70200). It probably lies between €120,000 and €260,000.Financials
Is DL PHARMACARE profitable?
In financial year 2025, DL PHARMACARE made a profit of €51,107.
Where can I find the annual accounts of DL PHARMACARE?
DL PHARMACARE filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.